MentionFoxMyris Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-10-14.
Sell to companies like these? Paste your website and see 10 with a filed reason to buy this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-14 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Myris Therapeutics, Inc.
Free to see. No signup.
We'll show it in your MentionFox inbox when Myris Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Myris Therapeutics, Inc. →Get the full cited report on Myris Therapeutics, Inc.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Myris Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Myris Therapeutics, Inc. See pricing
Trailing twelve months. 774 filings in Biotechnology, totalled by week. The dot is this raise, $500K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Laura Benjamin is named as Executive Officer and Director on the Form D that Myris Therapeutics, Inc. filed with the SEC on 14 October 2026, one of 8 people that filing names.
Rebecca Wolfe is named as Executive Officer on the Form D that Myris Therapeutics, Inc. filed with the SEC on 14 October 2026, one of 8 people that filing names.
Antonina Simakova is named as Executive Officer on the Form D that Myris Therapeutics, Inc. filed with the SEC on 14 October 2026, one of 8 people that filing names.
Alan Russell is named as Promoter on the Form D that Myris Therapeutics, Inc. filed with the SEC on 14 October 2026, one of 8 people that filing names.
David Colaizzi is named as Director on the Form D that Myris Therapeutics, Inc. filed with the SEC on 14 October 2026, one of 8 people that filing names.
Barbara Fox is named as Director on the Form D that Myris Therapeutics, Inc. filed with the SEC on 14 October 2026, one of 8 people that filing names.
Krzysztof Matyjaszewski is named as Director on the Form D that Myris Therapeutics, Inc. filed with the SEC on 14 October 2026, one of 8 people that filing names.
Mark Murcko is named as Director on the Form D that Myris Therapeutics, Inc. filed with the SEC on 14 October 2026, one of 8 people that filing names.
8 people named on the filing — 3 holding an executive role, 4 as directors only and 1 named in another capacity.
Named as of the 2026-10-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Myris Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Myris Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Myris Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Myris Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Myris Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/myris-therapeutics-inc-form-d-000004